Evidence map›Paper›PMID 39861952›Full record

ArticleAnnals of clinical and translational neurology2025

Pediatric, adult, and late onset multiple sclerosis: Cognitive phenotypes and gray matter atrophy.

Ermelinda De Meo, Emilio Portaccio, Rosa Cortese, Luis Ruano, Benedetta Goretti, Claudia Niccolai, Francesco Patti, Clara Chisari, Paolo Gallo, Paola Grossi and 14 more

Abstract read
In one paragraph

Article in Annals of clinical and translational neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Ermelinda De MeoDepartment of Neuroinflammation, Institute of Neurology, Univeristy College of London, London, UK.ORCID 0000-0001-5531-1111
Emilio PortaccioNEUROFARBA Department, Neurosciences Section, University of Florence, Florence, Italy.ORCID 0000-0002-9662-1762
Rosa CorteseDepartment of Medicine, Surgery and Neuroscience, University of Siena, Siena, Italy.ORCID 0000-0002-9803-7914
Luis RuanoEPIUnit, Instituto de Saúde Pública de Universidade do Porto, Porto, Portugal.
Benedetta GorettiDepartment of Neuroinflammation, Institute of Neurology, Univeristy College of London, London, UK.
Claudia NiccolaiDepartment of Neuroinflammation, Institute of Neurology, Univeristy College of London, London, UK.
Francesco PattiUniversity of Catania, Catania, Italy.ORCID 0000-0002-6923-0846
Clara ChisariUniversity of Catania, Catania, Italy.
Paolo GalloUniversity of Padova, Padova, Italy.
Paola GrossiDepartment, ASST Crema, Neuroimmunology Center, Cardiocerebrovascular, Crema, Italy.
Angelo GhezziGallarate Hospital, Varese, Italy.
Marco RoscioGallarate Hospital, Varese, Italy.
Flavia MattioliASST Spedali Civili Brescia Neuropsychology Unit, Brescia, Italy.
Chiara StampatoriASST Spedali Civili Brescia Neuropsychology Unit, Brescia, Italy.
Marta SimoneDepartment of Basic Medical Sciences, Child and Adolescence Neuropsychiatry Unit, Neuroscience and Sense Organs University "Aldo Moro" Bari, Bari, Italy.
Rosa Gemma ViterboDepartment of Basic Medical Sciences, Child and Adolescence Neuropsychiatry Unit, Neuroscience and Sense Organs University "Aldo Moro" Bari, Bari, Italy.
Raffaello BonacchiNeuroradiology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Assunta Maria RoccaNeuroimaging Research Unit, IRCCS San Raffaele Scientific Institute, Milan.ORCID 0000-0003-2358-4320
Elisa LeveraroDepartment of Neurology, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, University of Genoa, Genoa, Italy.
Antonio GiorgioDepartment of Medicine, Surgery and Neuroscience, University of Siena, Siena, Italy.
Nicola De StefanoDepartment of Medicine, Surgery and Neuroscience, University of Siena, Siena, Italy.
Massimo FilippiNeuroimaging Research Unit, IRCCS San Raffaele Scientific Institute, Milan.ORCID 0000-0002-5485-0479
Matilde IngleseDepartment of Neurology, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, University of Genoa, Genoa, Italy.
Maria Pia AmatoNEUROFARBA Department, Neurosciences Section, University of Florence, Florence, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesWe aim to investigate cognitive phenotype distribution and MRI correlates across pediatric-, elderly-, and adult-onset MS patients as a function of disease duration.

methodsIn this cross-sectional study, we enrolled 1262 MS patients and 238 healthy controls, with neurological and cognitive assessments. A subset of 222 MS patients and 92 controls underwent 3T-MRI scan for brain atrophy and lesion analysis. Multinomial probabilistic models identified likelihood of belonging to cognitive phenotypes ("preserved-cognition," "mild verbal memory/semantic fluency," "mild multi-domain," "severe attention/executive," and "severe multi-domain") and experiencing MRI abnormalities based on disease duration and age at onset.

resultsIn all groups, the likelihood of "preserved-cognition" phenotype decreased, whereas "mild multi-domain" increased with longer disease duration. In pediatric- and adult-onset patients, the likelihood of "mild verbal memory/semantic fluency" phenotypes decreased with longer disease duration, and that of "severe multi-domain" increased with longer disease duration. Only in adult-onset patients, the likelihood of "severe executive/attention" phenotype increased with longer disease duration. All groups displayed escalating probabilities of cortical, thalamic, hippocampal, and deep gray matter atrophy over disease course. Compared to adult, pediatric-onset patients showed lower probability of experiencing thalamic atrophy with longer disease duration, while elderly-onset showed higher probability of experiencing cortical and hippocampal atrophy.

interpretationAge at MS onset significantly influences the distribution of cognitive phenotypes and the patterns of regional gray matter atrophy throughout the disease course.

Indexed as

Cognitive DysfunctionGray MatterMultiple SclerosisAdolescentAdultAgedAge of OnsetAtrophyChildCross-Sectional StudiesFemaleHumansMagnetic Resonance ImagingMaleMiddle AgedPhenotype

Identifiers

PMID39861952
PMCPMC11920747

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.